You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.

We are looking for volunteers to participate in a clinical study to advance lupus treatment.

If you are interested in seeing if you may qualify for an ongoing clinical study, please contact Christina Ndolo at cmndolo@uabmc.edu.

Participate in the PRECISION-BP research study investigating the best time to take blood pressure medication, morning or evening. This study participants will receive blood pressure medications for 28 days. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB Hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Haley at PRECISION-BPSTUDY@uabmc.edu or call us at 205-975-5825 if you are interested.

The Denosumab for Type 1 Diabetes phase 1/2 clinical trial, is a collaborative study with the Arthur Riggs Diabetes and Metabolism Research Institute and the Center for Diabetes and Metabolic Diseases at Indiana University.

Michele Forman, Samantha Giordano-Mooga and Joe March demonstrated extraordinary commitment to engaging undergraduate students in service learning, undergraduate research and core teaching.

Hundreds of UAB employees met for lunch and conversation at the annual Staff Picnic on Oct. 4. Here are some of our favorite photos from the event.

There are several important things to keep in mind at UAB and UAB Medicine leading up to election day, as well as on and after Nov. 5, as a member of a community at a public university and academic medical center. 

This study is looking for healthy children and adolescents, ages 2 to 17 years old that are interested in getting a pneumonia vaccine. Most children get a pneumonia vaccine in the first year of life. This research study will be testing a new version of the pneumonia vaccine that is designed to protect your child against additional strains of pneumonia. This means your child will receive one dose of the updated version of the vaccine, PCV21, or your child will receive PCV20, the currently administered pneumonia vaccine in the U.S. You will be expected to accompany your child for 2 clinic visits that will include your child’s vaccine injection and 2 blood draws. You must complete two telephone visits as well. The study duration is 6 months. Your child may qualify for enrollment if they are healthy and are ages 7 months to 23 months, but have never had a pneumonia vaccine. Compensation will be provided. If you are interested in enrollment or need more information, please contact Alexis, Misty, or Sama at 205-638-2629. Email as well at mlpurser@uabmc.edu

Human Resources’ AWARE Disability Management Program is providing opportunities for employees to learn to recognize and engage with individuals with disabilities at UAB.

Completing mental health training is a great way for staff, faculty and students at UAB and UAB Medicine to share a culture of care and thriving. The UAB Enterprise Mental Health Advocate Program, recently introduced a new learning track to its lineup.